会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • N-IMIDAZOLYL- AND N-IMIDAZOLYLMETHYL-DERIVATIVES OF SUBSTITUTED BICYCLIC COMPOUNDS
    • 取代的双环化合物的N-咪唑并 - 和N-咪唑烷基甲基衍生物
    • WO1990003970A1
    • 1990-04-19
    • PCT/EP1989001159
    • 1989-10-03
    • FARMITALIA CARLO ERBA S.R.L.CARGANICO, GermanoCOZZI, PaoloPILLAN, AntonioSALVATI, PatriciaFERTI, Corrado
    • FARMITALIA CARLO ERBA S.R.L.
    • C07D233/56
    • C07D231/12C07D233/56C07D249/08
    • The present invention relates to new N-imidazolyl and N-imidazolylmethyl derivatives of bicyclic compounds having general formula (I), wherein A is an alpha or beta group, in which R3 is hydrogen or C1-C6 alkyl, or a psi group, in which each of R4 and R5 independently is hydrogen or C1-C5 alkyl; Z is -CH2-, -O- or -S-; n is zero or 1; each of R and R1 is independently hydrogen or C1-C6 alkyl; R2 is -COCH2OH, -CH2OR', -COOR', -CONR'R'' or -CH=CH-COOR', in which each of R' and R'' independently is hydrogen or C1-C6 alkyl, and the pharmaceutically acceptable salts thereof; and wherein: a) when n is zero, then Z is -CH2- or -O-; whereas when n is one, then Z is -CH2-, -O- or -S-; b) when A is alpha or beta in which R3 is hydrogen, then n is one; and c) when, at the same time, A is beta in which R3 is hydrogen, Z is -CH2-, n is one and R2 is -COOR' wherein R' is as defined above, then at least one of R and R1 is other than hydrogen, which are useful in the treatment of diseases related to an enhancement of TxA2 synthesis.
    • 本发明涉及具有通式(I)的双环化合物的新的N-咪唑基和N-咪唑基甲基衍生物,其中A是α或β基团,其中R3是氢或C1-C6烷基或psi基团, 其中R4和R5各自独立地为氢或C1-C5烷基; Z是-CH 2 - , - O-或-S-; n为零或1; R和R 1各自独立地为氢或C 1 -C 6烷基; R 2是-COCH 2 OH,-CH 2 OR',-COOR',-CONR'R“或-CH = CH-COOR',其中R'和R”各自独立地是氢或C 1 -C 6烷基, 可接受的盐; 并且其中:a)当n为0时,Z为-CH 2 - 或-O-; 而当n为1时,则Z为-CH 2 - , - O-或-S-; b)当A是其中R 3是氢时的α或β,则n是1; 和c)当同时A为β,其中R 3为氢时,Z为-CH 2 - ,n为1,R 2为-COOR',其中R'如上定义,则R和R 1中的至少一个 不同于氢,其可用于治疗与增强TxA2合成相关的疾病。
    • 4. 发明申请
    • PYRIDYL DERIVATIVES OF SUBSTITUTED BICYCLIC COMPOUNDS AND PROCESS FOR THEIR PREPARATION
    • 取代双环化合物的吡啶衍生物及其制备方法
    • WO1992011240A1
    • 1992-07-09
    • PCT/EP1991002104
    • 1991-11-07
    • FARMITALIA CARLO ERBA S.R.L.COZZI, PaoloPILLAN, AntonioBERTONE, LeoneSALVATI, Patricia
    • FARMITALIA CARLO ERBA S.R.L.
    • C07D213/55
    • C07D213/55C07D213/56
    • The present invention relates to new pyridyl derivatives of bicyclic compounds having general formula (I) wherein the symbol ------ represents a single or double bond; m is an integer of 1 to 3; R is hydrogen or a C1-C6 alkyl group; R1 is a -(CH2)n-COR3 group, wherein n is zero or an integer of 1 to 3 and R3 is an -OR4 or -N(R4R5) group in which each of R4 and R5 independently is hydrogen, C1-C6 alkyl optionally substituted by phenyl or phenyl; or a -(CH2)p-OR4 group wherein p is zero or an integer of 1 to 4 and R4 is as defined above; R2 is hydrogen or C1-C4 alkyl; or a pharmaceutically acceptable salt thereof; and wherein, when at the same time the symbol ------ is a single bond and R1 is a -(CH2)n-COR3 group in which n is as defined above and R3 is an OR4 group wherein R4 is hydrogen or unsubstituted C1-C6 alkyl, then at least one of R and R2 is other than hydrogen, which are useful in the treatment of diseases related to an enhancement of TxA2 synthesis.
    • 本发明涉及具有通式(I)的双环化合物的新的吡啶基衍生物,其中符号表示单键或双键; m为1〜3的整数。 R是氢或C 1 -C 6烷基; R1是 - (CH2)n-COR3基团,其中n是0或1〜3的整数,R3是-OR4或-N(R4R5)基团,其中R4和R5各自独立地是氢,C1-C6 任选被苯基或苯基取代的烷基; 或 - (CH 2)p-OR 4基团,其中p为0或1至4的整数,并且R 4如上所定义; R2是氢或C1-C4烷基; 或其药学上可接受的盐; 并且其中当符号同时为单键并且R 1为其中n如上述定义的 - (CH 2)n -COR 3基团,且R 3为OR 4基团,其中R 4为氢或 未取代的C 1 -C 6烷基,那么R和R 2中的至少一个不是氢,其可用于治疗与增强TxA2合成相关的疾病。